|
Treatment Options
|
Selective Factor Xa Inhibitor (Pentasaccharide)
Fondaparinux (Arixtra) is the only agent in this class that is currently being marketed in the United States. It works similarly to heparin by "thinning" blood to prevent or treat DVT. Fondaparinux has been found to work well for the prevention of DVT after someone has undergone knee replacement, hip replacement, or hip fracture surgery. It is available as an injection and can often be used at home because it does not require the extensive monitoring that heparin does. Drugs in the class
Fondaparinux Solution for Injection (Arixtra Solution for Injection) |
Note: The above information is intended to supplement, not substitute for, the expertise and judgment of your physician, pharmacist, or other healthcare professional. It is not intended to diagnose a health condition, but it can be used as a guide to help you decide if you should seek professional treatment or to help you learn more about your condition once it has been diagnosed.
|
